arrow
A

Andreas Weihofen

university of luxembourg
H指数:22
被引数:4,141

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Optimization of Thienopyrazine RNA-Splicing Modulators for the Treatment of Huntington’s Disease

发现和优化噻吩吡嗪类RNA剪接调节剂以治疗亨廷顿病

2026-03-170
PRE
Comparative assessment of binding and functional differences of clinical antibodies targeting α-synuclein in cellular models of Parkinson’s disease

临床抗体靶向α-突触核蛋白在帕金森病细胞模型中结合和功能差异的比较评估

2025-06-180
PRE
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice
2024-01-244
OAAI
Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease

在帕金森病的播种/扩散小鼠模型中,神经变性和神经炎症是相关的,但独立于 α-突触核蛋白包涵体

GLIA
IF5.1
2022-01-2936
OAAI
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease

Α-突触核蛋白反义寡核苷酸作为帕金森病的疾病缓解疗法

2021-03-0878
OA
The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release

帕金森氏病相关基因ITPKB通过调节ER到线粒体的钙释放来防止 α-突触核蛋白聚集

2020-12-2137
OAAI
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
2019-04-01151
OAAI